Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-27763

Single-particle
3.13 Å
EMD-27763
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-27763
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 8dww summary report (pdf.gz) Map and 8dww FULL report (pdf.gz)
EMICSS annotations (xml)

Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit)

EMD-27763

Single-particle
3.13 Å
EMD-27763
3D View Gallery
Deposition: 02/08/2022
Map released: 31/05/2023
Last modified: 28/05/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Chikungunya virus strain Senegal 37997, Homo sapiens
Sample: Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit)
Fitted models: 8dww

Deposition Authors: Adams LJ , Fremont DH
A chikungunya virus-like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans.
Raju S , Adams LJ , Earnest JT , Warfield K , Vang L , Crowe Jr JE , Fremont DH , Diamond MS
(2023) Sci Transl Med , 15 , eade8273 - eade8273
PUBMED: 37196061
DOI: doi:10.1126/scitranslmed.ade8273
ISSN: 1946-6242